Literature DB >> 25311777

Low vitamin D levels predict clinical features of schizophrenia.

Kristina Cieslak1, Jordyn Feingold1, Daniel Antonius2, Julie Walsh-Messinger3, Roberta Dracxler1, Mary Rosedale1, Nicole Aujero1, David Keefe4, Deborah Goetz1, Raymond Goetz1, Dolores Malaspina5.   

Abstract

Vitamin D plays crucial roles in neuroprotection and neurodevelopment, and low levels are commonly associated with schizophrenia. We considered if the association was spurious or causal by examining the association of Vitamin D with Leukocyte Telomere Length (LTL), a marker of cellular aging. Vitamin D levels in 22 well-characterized schizophrenia cases were examined with respect to symptoms, cognition, and functioning. LTL was assessed using quantitative polymerase chain reaction (qPCR). The results showed that 91% (20) had deficient or insufficient Vitamin D levels, which were associated with excitement and grandiosity, social anhedonia, and poverty of speech. Sex-specific analyses showed strong associations of hypovitamintosis D to negative symptoms and decreased premorbid adjustment in males, and to lesser hallucinations and emotional withdrawal, but increased anti-social aggression in females. In females LTL was furthermore associated with Vitamin D levels. This study demonstrates a relationship of low vitamin D levels with increased cellular aging in females. It is also the first study to demonstrate potential sex-specific profiles among schizophrenia cases with hypovitaminosis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aggression; Hypovitaminosis D; Negative symptoms; Schizophrenia; Telomere length; Vitamin D

Mesh:

Substances:

Year:  2014        PMID: 25311777      PMCID: PMC4252834          DOI: 10.1016/j.schres.2014.08.031

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  26 in total

1.  Oxidative stress shortens telomeres.

Authors:  Thomas von Zglinicki
Journal:  Trends Biochem Sci       Date:  2002-07       Impact factor: 13.807

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Rapid telomere erosion in schizophrenia.

Authors:  H-T Kao; R M Cawthon; L E Delisi; H C Bertisch; F Ji; D Gordon; P Li; M M Benedict; W M Greenberg; B Porton
Journal:  Mol Psychiatry       Date:  2008-02       Impact factor: 15.992

4.  Vitamin D supplements in geriatric major depression.

Authors:  Stamatoula Zanetidou; Martino Belvederi Murri; Angela Buffa; Nazzarena Malavolta; Fernando Anzivino; Klea Bertakis
Journal:  Int J Geriatr Psychiatry       Date:  2011-11       Impact factor: 3.485

5.  Assessment of life history of aggression: development and psychometric characteristics.

Authors:  E F Coccaro; M E Berman; R J Kavoussi
Journal:  Psychiatry Res       Date:  1997-12-05       Impact factor: 3.222

6.  Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia.

Authors:  K A Graham; R S Keefe; J A Lieberman; A S Calikoglu; K M Lansing; D O Perkins
Journal:  Early Interv Psychiatry       Date:  2014-02-24       Impact factor: 2.732

7.  Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis.

Authors:  Emilio Fernandez-Egea; Miguel Bernardo; Christopher M Heaphy; Jeffrey K Griffith; Eduard Parellada; Enric Esmatjes; Ignacio Conget; Linh Nguyen; Varghese George; Hubert Stöppler; Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2009-03-11       Impact factor: 9.306

Review 8.  Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease.

Authors:  Darryl W Eyles; Thomas H J Burne; John J McGrath
Journal:  Front Neuroendocrinol       Date:  2012-07-11       Impact factor: 8.606

9.  In African American type 2 diabetic patients, is vitamin D deficiency associated with lower blood levels of hydrogen sulfide and cyclic adenosine monophosphate, and elevated oxidative stress?

Authors:  Sushil K Jain; Prasenjit Manna; David Micinski; Benjamin J Lieblong; Gunjan Kahlon; Lester Morehead; Robert Hoeldtke; Pat Farrington Bass; Steven N Levine
Journal:  Antioxid Redox Signal       Date:  2012-09-13       Impact factor: 8.401

Review 10.  So depression is an inflammatory disease, but where does the inflammation come from?

Authors:  Michael Berk; Lana J Williams; Felice N Jacka; Adrienne O'Neil; Julie A Pasco; Steven Moylan; Nicholas B Allen; Amanda L Stuart; Amie C Hayley; Michelle L Byrne; Michael Maes
Journal:  BMC Med       Date:  2013-09-12       Impact factor: 8.775

View more
  20 in total

Review 1.  Physical Exercise Alleviates Health Defects, Symptoms, and Biomarkers in Schizophrenia Spectrum Disorder.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-07-15       Impact factor: 3.911

2.  Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.

Authors:  L Kelley; A F P Sanders; E A Beaton
Journal:  J Dev Orig Health Dis       Date:  2016-12       Impact factor: 2.401

3.  Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.

Authors:  G Fond; M Faugere; C Faget-Agius; M Cermolacce; R Richieri; L Boyer; C Lançon
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-08-04       Impact factor: 5.270

4.  Vitamin D Deficiency and Depressive Symptomatology in Psychiatric Patients Hospitalized with a Current Depressive Episode: A Factor Analytic Study.

Authors:  Roland von Känel; Nasser Fardad; Nadine Steurer; Nicole Horak; Esther Hindermann; Franz Fischer; Katharina Gessler
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

Review 5.  Molecular substrates of schizophrenia: homeostatic signaling to connectivity.

Authors:  M A Landek-Salgado; T E Faust; A Sawa
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

6.  Vitamin D Deficiency in Adult Patients with Schizophreniform and Autism Spectrum Syndromes: A One-Year Cohort Study at a German Tertiary Care Hospital.

Authors:  Dominique Endres; Rick Dersch; Oliver Stich; Armin Buchwald; Evgeniy Perlov; Bernd Feige; Simon Maier; Andreas Riedel; Ludger Tebartz van Elst
Journal:  Front Psychiatry       Date:  2016-10-06       Impact factor: 4.157

7.  Higher Dietary Inflammation in Patients with Schizophrenia: A Case-Control Study in Korea.

Authors:  Hee Yun Cha; Soo Jin Yang; Sung-Wan Kim
Journal:  Nutrients       Date:  2021-06-13       Impact factor: 5.717

8.  The psychotropic effect of vitamin D supplementation on schizophrenia symptoms.

Authors:  Aras Neriman; Yilmaz Hakan; Ucuncu Ozge
Journal:  BMC Psychiatry       Date:  2021-06-15       Impact factor: 3.630

9.  Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2015-10-15       Impact factor: 5.923

10.  Periodic catatonia with long-term treatment: a case report.

Authors:  Ruei-An Chen; Tiao-Lai Huang
Journal:  BMC Psychiatry       Date:  2017-09-29       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.